Engineering and Development

Management and Executive

Product Management

Chief Executive Officer (CEO)

Chief Financial Officer

Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

Ambry Genetics announces improved EHR-integrated BC risk assessment solution

Kuehn Law Encourages Investors of Tempus AI, Inc. to Contact Law Firm

Tempus AI Adds Digital Pathology to Cancer Portfolio With Paige Acquisition

AI Omics Scientist III

Ambry Genetics is a CAP-accredited and CLIA-licensed molecular genetics laboratory dedicated to understanding and treating human diseases through genetics. They are seeking an AI Omics Scientist III who will lead the development of AI/ML solutions for genomic and multi-omics research, working cross-functionally with various teams to design and deploy models in high-performance environments.

Senior Talent Acquisition Partner

Sign up with Google

Sign in with Google